Targeting the autophagy promoted antitumor effect of T-DM1 on HER2-positive gastric cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting the autophagy promoted antitumor effect of T-DM1 on HER2-positive gastric cancer
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 12, Issue 4, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-03-17
DOI
10.1038/s41419-020-03349-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Exosome-transmitted miR-567 reverses trastuzumab resistance by inhibiting ATG5 in breast cancer
- (2020) Mingli Han et al. Cell Death & Disease
- Targeting PARP and autophagy evoked synergistic lethality in hepatocellular carcinoma
- (2019) Wenjing Zai et al. CARCINOGENESIS
- HER2-targeted therapies — a role beyond breast cancer
- (2019) Do-Youn Oh et al. Nature Reviews Clinical Oncology
- HER2 and Breast Cancer — A Phenomenal Success Story
- (2019) Daniel F. Hayes NEW ENGLAND JOURNAL OF MEDICINE
- HER2-Overexpressing/Amplified Breast Cancer as a Testing Ground for Antibody–Drug Conjugate Drug Development in Solid Tumors
- (2019) Mark D. Pegram et al. CLINICAL CANCER RESEARCH
- Inhibition of autophagy potentiated the anti-tumor effects of VEGF and CD47 bispecific therapy in glioblastoma
- (2018) Xuyao Zhang et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- EGFRvIII expression triggers a metabolic dependency and therapeutic vulnerability sensitive to autophagy inhibition
- (2018) Barry Jutten et al. Autophagy
- T-DM1 and brain metastases: clinical outcome in HER2-positive metastatic breast cancer
- (2018) Alessandra Fabi et al. BREAST
- Increased autophagy blocks HER2-mediated breast tumorigenesis
- (2018) Silvia Vega-Rubín-de-Celis et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- STAT3 activation confers trastuzumab-emtansine (T-DM1) resistance in HER2-positive breast cancer
- (2018) Lei Wang et al. CANCER SCIENCE
- Hedgehog Signaling Pathway and Autophagy in Cancer
- (2018) Xian Zeng et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Activating Autophagy Enhanced the Antitumor Effect of Antibody Drug Conjugates Rituximab-Monomethyl Auristatin E
- (2018) Yichen Wang et al. Frontiers in Immunology
- MMP7 Induces T-DM1 Resistance and Leads to The Poor Prognosis of Gastric Adenocarcinoma via a DKK1-Dependent Manner
- (2018) Hua Li et al. Anti-Cancer Agents in Medicinal Chemistry
- Antibody-drug conjugates (ADCs) for cancer therapy: Strategies, challenges, and successes
- (2018) Meghdad Abdollahpour-Alitappeh et al. JOURNAL OF CELLULAR PHYSIOLOGY
- The multifaceted role of autophagy in cancer and the microenvironment
- (2018) Hendrik Folkerts et al. MEDICINAL RESEARCH REVIEWS
- Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer
- (2018) Gunter von Minckwitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Autophagy and its role in gastric cancer
- (2018) Yijing Cao et al. CLINICA CHIMICA ACTA
- Breast cancer
- (2017) Nadia Harbeck et al. LANCET
- Trastuzumab emtansine versus taxane use for previously treated HER2-positive locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma (GATSBY): an international randomised, open-label, adaptive, phase 2/3 study
- (2017) Peter C Thuss-Patience et al. LANCET ONCOLOGY
- A novel and promising therapeutic approach for NSCLC: recombinant human arginase alone or combined with autophagy inhibitor
- (2017) Weitao Shen et al. Cell Death & Disease
- Targeting CD47 and Autophagy Elicited Enhanced Antitumor Effects in Non–Small Cell Lung Cancer
- (2017) Xuyao Zhang et al. Cancer Immunology Research
- Targeting the MIR34C-5p-ATG4B-autophagy axis enhances the sensitivity of cervical cancer cells to pirarubicin
- (2016) Yaran Wu et al. Autophagy
- Inhibition of autophagy overcomes the nanotoxicity elicited by cadmium-based quantum dots
- (2016) Jiajun Fan et al. BIOMATERIALS
- Autophagy, Inflammation, and Immunity: A Troika Governing Cancer and Its Treatment
- (2016) Zhenyu Zhong et al. CELL
- Gastric cancer
- (2016) Eric Van Cutsem et al. LANCET
- Antibody-drug conjugates: recent advances in conjugation and linker chemistries
- (2016) Kyoji Tsuchikama et al. Protein & Cell
- Targeting Hedgehog signaling pathway and autophagy overcomes drug resistance of BCR-ABL-positive chronic myeloid leukemia
- (2015) Xian Zeng et al. Autophagy
- Cocaine-Mediated Autophagy in Astrocytes Involves Sigma 1 Receptor, PI3K, mTOR, Atg5/7, Beclin-1 and Induces Type II Programed Cell Death
- (2015) Lu Cao et al. MOLECULAR NEUROBIOLOGY
- Autophagy Protects from Trastuzumab-Induced Cytotoxicity in HER2 Overexpressing Breast Tumor Spheroids
- (2015) Cristina E. Rodríguez et al. PLoS One
- Autophagy-mediated regulation of macrophages and its applications for cancer
- (2014) Peiwen Chen et al. Autophagy
- Antibody–drug conjugates—A new wave of cancer drugs
- (2014) Hervé Bouchard et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- The role of PI3K/AKT/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration
- (2014) David Heras-Sandoval et al. CELLULAR SIGNALLING
- HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer
- (2014) Eric Van Cutsem et al. Gastric Cancer
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Targeting of preexisting and induced breast cancer stem cells with trastuzumab and trastuzumab emtansine (T-DM1)
- (2014) J Diessner et al. Cell Death & Disease
- HER2 status in gastric cancers: a retrospective analysis from four Chinese representative clinical centers and assessment of its prognostic significance
- (2013) W. Q. Sheng et al. ANNALS OF ONCOLOGY
- HER2-positive gastric cancer
- (2013) Narikazu Boku Gastric Cancer
- Interaction between Her2 and Beclin-1 Proteins Underlies a New Mechanism of Reciprocal Regulation
- (2013) Jie Han et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Clinicopathological and prognostic significance of Ki-67, caspase-3 and p53 expression in gastric carcinomas
- (2013) LI-JUN XIAO et al. Oncology Letters
- A Multicenter Phase I Trial of PX-866, an Oral Irreversible Phosphatidylinositol 3-Kinase Inhibitor, in Patients with Advanced Solid Tumors
- (2012) D. S. Hong et al. CLINICAL CANCER RESEARCH
- Catabolic Fate and Pharmacokinetic Characterization of Trastuzumab Emtansine (T-DM1): an Emphasis on Preclinical and Clinical Catabolism
- (2012) Ben-Quan Shen et al. CURRENT DRUG METABOLISM
- The Effect of Different Linkers on Target Cell Catabolism and Pharmacokinetics/Pharmacodynamics of Trastuzumab Maytansinoid Conjugates
- (2012) H. K. Erickson et al. MOLECULAR CANCER THERAPEUTICS
- HER2 as a Prognostic Marker in Gastric Cancer - A Systematic Analysis of Data from the Literature
- (2012) Jan Trøst Jørgensen et al. Journal of Cancer
- Phase I, Dose-Escalation Study of BKM120, an Oral Pan-Class I PI3K Inhibitor, in Patients With Advanced Solid Tumors
- (2011) Johanna C. Bendell et al. JOURNAL OF CLINICAL ONCOLOGY
- Role of non-canonical Beclin 1-independent autophagy in cell death induced by resveratrol in human breast cancer cells
- (2008) F Scarlatti et al. CELL DEATH AND DIFFERENTIATION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More